Results 81 to 90 of about 1,366,518 (256)

Using cell‐free RNA to identify B‐ and T‐cell clonality for diagnosis and monitoring of B‐ and T‐cell neoplasms

open access: yesFEBS Open Bio, EarlyView.
Using peripheral blood for determining B‐cell or T‐cell clonality is more reliable when we use cell‐free RNA (cfRNA) because cells release blood significantly more RNA than DNA. Next‐generation sequencing (NGS) of cfRNA allows us to evaluate fragment cfRNA and evaluate clonality reliably without the need for prior determination of the specific dominant
Adam Albitar   +11 more
wiley   +1 more source

Five‐Year Disease Progression in Synuclein Seeding Positive Sporadic Parkinson's Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To provide a comprehensive description of disease progression in synuclein seeding assay (SAA) positive sporadic Parkinson Disease participants, using Neuronal Synuclein Disease integrated biological and functional impairment staging framework.
Paulina Gonzalez‐Latapi   +19 more
wiley   +1 more source

The Marquis de la Roche document

open access: yes, 2012
Included with this document is a map showing Sable Island, where La Roche landed his colonists in 1598. The map contains an inset picturing La Roche's colonists on Sable Island sighting the rescue ship in 1603.Document mounted in red padded leather ...
Marquis de la Roche   +1 more
core   +1 more source

Highly sensitive and accurate detection of C-reactive protein by CdSe/ZnS quantum dot-based fluorescence-linked immunosorbent assay

open access: yesJournal of Nanobiotechnology, 2017
Background The conventional and widely used enzyme-linked immunosorbent assays (ELISA), due to specificity and high-sensitivity, were suitable in vitro diagnosis.
Yanbing Lv   +8 more
doaj   +1 more source

Roche, Kathleen. Kathleen Roche discusses nursing practices in Newfoundland

open access: yes, 2001
Roche graduated from The General Hospital School of Nursing in 1949 and talks about nursing school and her experiences as a public health nurse, a head nurse and her time in nursing ...
Beaton, Marilyn
core  

Onasemnogene Abeparvovec in Type I Spinal Muscular Atrophy: 24‐Month Follow‐Up From the Italian Registry

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane   +43 more
wiley   +1 more source

Interview with Jimmy Limit: "Recent Advancements"

open access: yes, 2014
Jimmy Limit\u27s "Recent Advancements" (18 Jan-4 May 2014) at Rodman Hall, St. Catharines, Ontario.
Limit, Jimmy
core   +1 more source

Roche, Phil, and Roche, Mary. Interview about living in Logy Bay-Middle Cove-Outer Cove

open access: yes, 2010
An interview with Phil and Mary Roche conducted in 2010 by Gillian Kinsella for the Logy Bay-Middle Cove-Outer Cove Museum. Phil and Mary Roche talk about life in Logy Bay-Middle Cove-Outer Cove, including saltbox houses, St. Fancis of Assisi School, the
Kinsella, Gillian
core  

The plastic limit of clays [PDF]

open access: yes, 2013
The plastic limit of soils was first described by Atterberg in 1911. The thread-rolling test was standardised at the US Public Roads Bureau in the 1920s and 1930s, and has subsequently become one of the standard tests of soil mechanics.
Vardanega, Paul J   +2 more
core   +1 more source

Reperfusion‐Dependent Outcomes After Endovascular Thrombectomy Stratified by NIHSS‐ASPECTS Clinical‐Core Mismatch

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This analysis evaluates the effect of successful reperfusion on functional outcomes after MT, stratified by admission National Institutes of Health Stroke Scale (NIHSS) and Alberta Stroke Program Early CT Score (ASPECTS) as surrogates for clinical‐core mismatch, using multicenter registry data.
Felix Schlicht   +53 more
wiley   +1 more source

Home - About - Disclaimer - Privacy